We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OTC Monograph Drug Appeal of Final Order is Subject of FDA Guidance
OTC Monograph Drug Appeal of Final Order is Subject of FDA Guidance
CDER formal dispute resolution (FDR) procedures on how to appeal a final order for OTC monograph drugs are outlined in a draft guidance the FDA released on Thursday.